Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

From transcriptome analysis to therapeutic anti-CD40L treatment in the SOD1 model of amyotrophic lateral sclerosis

28 Mar 2010

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Amyotrophic Lateral Sclerosis Research
Share to Neurogenetic and Muscular Disorders Research
Share to RNA Research and Splicing

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 20348957
DOI: 10.1038/ng.557

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

From transcriptome analysis to therapeutic anti-CD40L treatment in the SOD1 model of amyotrophic lateral sclerosisPMID 20348957Read ↗

Upregulated miR-10b-5p as a potential miRNA signature in amyotrophic lateral sclerosis patientsSemantic proximity Read ↗

Gene expression analysis of the murine model of amyotrophic lateral sclerosis: Studies of the Leu126delTT mutation in SOD1Semantic proximity Read ↗

SOD1 and TDP-43 animal models of amyotrophic lateral sclerosis: recent advances in understanding disease toward the development of clinical treatmentsSemantic proximity Read ↗

Amyotrophic lateral sclerosis caused by SOD1 variants: from genetic discovery to disease preventionSemantic proximity Read ↗

Genomic and transcriptomic advances in amyotrophic lateral sclerosisSemantic proximity Read ↗

Tofersen in SOD1-associated amyotrophic lateral sclerosis: From molecular mechanisms to regulatory milestones.Semantic proximity Read ↗

Selective removal of misfolded SOD1 delays disease onset in a mouse model of amyotrophic lateral sclerosisSemantic proximity Read ↗

Exploring dysregulated miRNAs in ALS: implications for disease pathogenesis and early diagnosisSemantic proximity Read ↗

Harnessing Transcriptomic Signals for Amyotrophic Lateral Sclerosis to Identify Novel Drugs and Enhance Risk PredictionSemantic proximity Read ↗

An update on superoxide dismutase 1 in familial amyotrophic lateral sclerosis.Semantic proximity Read ↗

MicroRNAs: newcomers into the ALS picture.Semantic proximity Read ↗

Silence superoxide dismutase 1 (SOD1): a promising therapeutic target for amyotrophic lateral sclerosis (ALS).Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.